Search research articles
Contact Us
Filters
Showing results (631-640 of 643) with videos related to
Page
of 65
Sort By:
The Journal of Clinical Investigation
|
June 1, 2021
SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection
Tsung-Yu Tsai, Ming-Ting Huang, Pei-Shan Sung, et al.
The Journal of Experimental Medicine
|
January 17, 2025
Cigarette smoke components modulate the MR1-MAIT axis
Wael Awad, Jemma R Mayall, Weijun Xu, et al.
BMJ Open
|
January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
Hanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
JACS Au
|
October 31, 2022
Metal Complexes as Antifungals? From a Crowd-Sourced Compound Library to the First <i>In Vivo</i> Experiments
Angelo Frei, Alysha G Elliott, Alex Kan, et al.
The American Journal of Cardiology
|
July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial
Jeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Heart (British Cardiac Society)
|
August 16, 2023
Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement
Mi Hee Jang, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions
|
December 27, 2023
Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve Replacement
Yeonwoo Choi, Jung-Min Ahn, Do-Yoon Kang, et al.
Circulation
|
April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial
Duk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.
Science Translational Medicine
|
April 1, 2026
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Jialun Zhu, Xuanbing Cheng, Mohammadreza Bahramian, et al.
American Heart Journal
|
December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial
Mijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
Page
of 65
Search research articles
Search
Showing results (631-640 of 643) with videos related to
Sort By:
Page
of 65
The Journal of Clinical Investigation
|
June 1, 2021
SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection
Tsung-Yu Tsai, Ming-Ting Huang, Pei-Shan Sung, et al.
The Journal of Experimental Medicine
|
January 17, 2025
Cigarette smoke components modulate the MR1-MAIT axis
Wael Awad, Jemma R Mayall, Weijun Xu, et al.
BMJ Open
|
January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
Hanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
JACS Au
|
October 31, 2022
Metal Complexes as Antifungals? From a Crowd-Sourced Compound Library to the First <i>In Vivo</i> Experiments
Angelo Frei, Alysha G Elliott, Alex Kan, et al.
The American Journal of Cardiology
|
July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial
Jeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Heart (British Cardiac Society)
|
August 16, 2023
Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement
Mi Hee Jang, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions
|
December 27, 2023
Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve Replacement
Yeonwoo Choi, Jung-Min Ahn, Do-Yoon Kang, et al.
Circulation
|
April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial
Duk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.
Science Translational Medicine
|
April 1, 2026
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Jialun Zhu, Xuanbing Cheng, Mohammadreza Bahramian, et al.
American Heart Journal
|
December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial
Mijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
Page
of 65